Why should results from metastatic trials no longer matter for early-stage disease?

J Clin Oncol. 2013 Jul 20;31(21):2753. doi: 10.1200/JCO.2012.48.5508. Epub 2013 Jun 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Female
  • Humans
  • Postmenopause / genetics*
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Cytochrome P-450 CYP2D6